NIH Logo
May 20, 2016
Vol. LXVIII, No. 11


previous story

previous story

NIAAA Seeks Study Subjects

Researchers at the National Institute on Aging seek participants with mild cognitive impairment or early stage Alzheimer’s disease. Researchers are investigating a drug called “exendin-4” (exenatide, trade name Byetta). The study will see if the injection of exendin-4 is safe and how it affects brain chemistry and memory in people with mild cognitive impairment or mild Alzheimer’s disease. There is no cost for study-related tests or medications. For more information, call the Office of Patient Recruitment, 1-866-444-2214 (TTY 1-866-411- 1010). Refer to study 10-AG-0423.

back to top of page